Clinical Trial

Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study

Study acronym: AD-FMT
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to assess the feasibility and safety of faecal microbiota transplantation for Alzheimer's disease.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-04-23
notable Primary completion pushed: 2026-06 -> 2026-10 2026-04-23
Trial Details
NCT Number NCT07332260
Lead Sponsor University Hospital of North Norway
Collaborators: UiT The Arctic University of Norway
Conditions Alzheimer s Disease, Faecal Microbiota Transplantation (FMT)
Enrollment 10 participants
Start Date 2026-05
Primary Completion 2026-10 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-22